The Results of Multiple Aspirations and Injections of Unicameral Bone Cyst by Methyl Prednisolone Acetate
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03724630 |
Recruitment Status : Unknown
Verified May 2018 by michael moured, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : October 30, 2018
Last Update Posted : October 30, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Simple Bone Cyst |
unicameral bone cysts (UBCs) are benign, fluid-filled cavities that develop in tubular and flat bones (eg,humerus, femur). These cysts tend to expand and weaken the local bone,but they are not true neoplasms. In 1876, Virchow1 first described these lesions as cystic structures caused by abnormalities in local circulation.
UBCs are also known as simple or solitary bone cysts. They occur almost exclusively in children and adolescents (up to 85% of cases), with a reported peak between ages 3 and14 years and the average age at diagnosis being 9 years.
These lesions represent approximately 3% of all bone tumors and occur more commonly in boys than in girls (2:1). Several treatment options exist for unicameral bone cysts (UBCs), including observation, steroid injection, bone marrow injection, and Surgical procedures have ranged from simple curettage with autologous bone graft or allograft to sub periosteal resection with internal fixation and grafting
.Treatment by multiple injection of steroids produce minimal surgical approach, no hospital stay, and very low morbidity. Three or four injections over a period of 12 month may be enough
Study Type : | Observational |
Estimated Enrollment : | 15 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Results of Multiple Aspirations and Injections of Unicameral Bone Cyst by Methyl Prednisolone Acetate |
Estimated Study Start Date : | January 1, 2019 |
Estimated Primary Completion Date : | January 1, 2020 |
Estimated Study Completion Date : | March 1, 2020 |
- radiological healing of simple bone cyst [ Time Frame: one month after injection ]
-
Modified Neer classification
- Healed cyst : Cyst filled by new bone, with or without small radiolucent area(s) < 1 cm in size
- Healing with defect: Radiolucent area(s) < 50% of the diameter of bone, with enough cortical thickness to prevent fracture
- Persistent cyst: Radiolucent area > 50% of diameter of the bone and with a thin cortical rim. No increase in the size of the cyst. Continued restriction of activity or repeated treatment is required
- Recurrent cyst: Cyst reappeared in a previously obliterated area, or a residual radiolucent area has increased in size
- the cyst index which predict the risk of pathological fracture .The cyst index can be calculated as the area of the cyst divided by the square of the diaphysis diameter cyst index equal to or greater than 3.5 indicates a high fracture risk
-
- improvement of symptoms [ Time Frame: one month after injection ]clinical healing by asking the patient or his relevant about improvement of symptoms

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Each patient will receive a maximum of three or four injections, with at least three months between injections. The indication for a second or third injection will be based on the surgeon's judgment regarding whether the cyst will be healed or not..
Injections will be performed with the patient under general anesthesia. Under image intensifier. The diagnosis of a unicameral bone cyst will be confirmed by needle aspiration of clear or straw-colored fluid.
- Methylprednisolone acetate, 3 mg/cm3 of cyst volume with amaximum dose of 180 mg will be injected into the cyst .
If the cyst was multilocular, each cavity will be injected separately follow up of patients by radiological and clinical outcomes
Inclusion Criteria:
- age .: all children eighteen years of age or younger with unicameral bone cyst
- Patient with previous fracture on top of unicameral bone cyst
Exclusion Criteria:
- patient age more than 18 years old
- patients with malignant tumors
- patients on chronic steroid treatment
- pregnancy

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03724630
Contact: michael M. gerges | 01201885642 | madred_man72@yahoo.com |
Responsible Party: | michael moured, principal investigator, Assiut University |
ClinicalTrials.gov Identifier: | NCT03724630 |
Other Study ID Numbers: |
Assuit University 8000 |
First Posted: | October 30, 2018 Key Record Dates |
Last Update Posted: | October 30, 2018 |
Last Verified: | May 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | radiological follow up of patients after one month of injection follow up again by x.ray after three months clinical outcome of patients after injection by visual analogue scale of pain |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Cysts Bone Cysts Neoplasms |
Pathological Conditions, Anatomical Bone Diseases Musculoskeletal Diseases |